#begin document (en_1306.txt); part 000
en_1306.txt	0	0	Dying	NN	(TOP(FRAG(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	2	Grow	CD	(NP*))	-	-	-	-	*	-
en_1306.txt	0	3	?	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	STANFORD	NNP	(TOP(NP(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	–	NNP	(NP*)	-	-	-	-	*	-
en_1306.txt	0	2	We	PRP	(S(NP*)	-	-	-	-	*	(0)
en_1306.txt	0	3	are	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	constantly	RB	(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	5	bombarded	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	6	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	7	information	NN	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	8	about	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	10	purported	JJ	*	-	-	-	-	*	-
en_1306.txt	0	11	risks	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	12	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	13	protective	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	14	effects	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	16	one	CD	(NP*	-	-	-	-	*	-
en_1306.txt	0	17	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	18	another	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	19	food	NN	*	-	-	-	-	*	-
en_1306.txt	0	20	,	,	*	-	-	-	-	*	-
en_1306.txt	0	21	dietary	JJ	*	-	-	-	-	*	-
en_1306.txt	0	22	supplement	NN	*	-	-	-	-	*	-
en_1306.txt	0	23	,	,	*	-	-	-	-	*	-
en_1306.txt	0	24	chemical	NN	*	-	-	-	-	*	-
en_1306.txt	0	25	,	,	*	-	-	-	-	*	-
en_1306.txt	0	26	drug	NN	*	-	-	-	-	*	-
en_1306.txt	0	27	,	,	*	-	-	-	-	*	-
en_1306.txt	0	28	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	29	activity	NN	*)))))))))))	-	-	-	-	*	-
en_1306.txt	0	30	.	.	*)	-	-	-	-	*	-
en_1306.txt	0	31	&	CC	*	-	-	-	-	*	-
en_1306.txt	0	32	#	#	(NP*	-	-	-	-	*	-
en_1306.txt	0	33	160	CD	*)	-	-	-	-	*	-
en_1306.txt	0	34	;	:	*))	-	-	-	-	*	-

en_1306.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1306.txt	0	1	July	NNP	(NP*))	-	-	-	-	*	-
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	4	example	NN	(NP*))	-	-	-	-	*	-
en_1306.txt	0	5	,	,	*	-	-	-	-	*	-
en_1306.txt	0	6	an	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	7	article	NN	*)	-	-	-	-	*	-
en_1306.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	The	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	10	Annals	NNPS	*)	-	-	-	-	*	-
en_1306.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	12	Internal	NNP	(NP*	-	-	-	-	*	-
en_1306.txt	0	13	Medicine	NNP	*)))))	-	-	-	-	*	-
en_1306.txt	0	14	reported	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	15	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	16	people	NNS	(S(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	17	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	18	work	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	19	at	IN	(NP(NP(QP*	-	-	-	-	*	-
en_1306.txt	0	20	least	JJS	*	-	-	-	-	*	-
en_1306.txt	0	21	11	CD	*)	-	-	-	-	*	-
en_1306.txt	0	22	hours	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	23	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	24	day	NN	*))))))	-	-	-	-	*	-
en_1306.txt	0	25	have	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	26	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	27	67	CD	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	28	%	NN	*)	-	-	-	-	*	-
en_1306.txt	0	29	higher	JJR	*	-	-	-	-	*	-
en_1306.txt	0	30	risk	NN	*)	-	-	-	-	*	-
en_1306.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	32	having	VBG	(S(VP(VP*	-	-	-	-	*	-
en_1306.txt	0	33	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	34	heart	NN	*	-	-	-	-	*	-
en_1306.txt	0	35	attack	NN	*))	-	-	-	-	*	-
en_1306.txt	0	36	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	37	dying	VBG	(VP*	-	-	-	-	*	-
en_1306.txt	0	38	from	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	39	heart	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	40	disease	NN	*))))))	-	-	-	-	*	-
en_1306.txt	0	41	than	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	42	those	DT	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	43	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	44	work	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	45	7-8	CD	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	46	hours	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	47	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	48	day	NN	*))))))))))))	-	-	-	-	*	-
en_1306.txt	0	49	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	However	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	1	,	,	*	-	-	-	-	*	-
en_1306.txt	0	2	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	3	study	NN	*	-	-	-	-	*	-
en_1306.txt	0	4	cannot	NN	*)	-	-	-	-	*	-
en_1306.txt	0	5	conclude	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	7	long	JJ	(S(NP*	-	-	-	-	*	-
en_1306.txt	0	8	work	NN	*	-	-	-	-	*	-
en_1306.txt	0	9	hours	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	10	cause	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	11	cardiac	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	12	disease	NN	*)))))	-	-	-	-	*	-
en_1306.txt	0	13	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1306.txt	0	1	fact	NN	(NP*))	-	-	-	-	*	-
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	one	CD	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	4	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	6	most	RBS	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	7	common	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	8	misunderstandings	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	9	about	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	10	scientific	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	11	studies	NNS	*)))))	-	-	-	-	*	-
en_1306.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	14	critical	JJ	*	-	-	-	-	*	-
en_1306.txt	0	15	difference	NN	*)	-	-	-	-	*	-
en_1306.txt	0	16	between	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	correlation	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	19	causation	NN	*))))	-	-	-	-	*	-
en_1306.txt	0	20	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Working	NNP	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	long	JJ	*	-	-	-	-	*	-
en_1306.txt	0	2	days	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	3	might	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	only	RB	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	6	a	DT	*	-	-	-	-	*	-
en_1306.txt	0	7	marker	NN	*)	-	-	-	-	*	-
en_1306.txt	0	8	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	being	VBG	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	10	at	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	11	higher	JJR	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	12	risk	NN	*)	-	-	-	-	*	-
en_1306.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	14	heart	NN	(NP*	-	-	-	-	*	(1
en_1306.txt	0	15	disease	NN	*))))))))))	-	-	-	-	*	1)
en_1306.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1306.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	-
en_1306.txt	0	4	could	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	7	highly	RB	(S(NP(NP(ADJP*	-	-	-	-	*	-
en_1306.txt	0	8	stressed	VBN	*)	-	-	-	-	*	-
en_1306.txt	0	9	people	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	10	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	11	Type	NNP	(NP*))	-	-	-	-	*	-
en_1306.txt	0	12	A	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	13	personality	NN	*)	-	-	-	-	*	-
en_1306.txt	0	14	who	WP	(SBAR(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	15	think	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	16	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	17	bacon	NN	(S(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	18	cheeseburgers	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	20	creamy	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	21	sauces	NNS	*))	-	-	-	-	*	-
en_1306.txt	0	22	are	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	23	staple	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	24	foods	NNS	*)))))))	-	-	-	-	*	-
en_1306.txt	0	25	,	,	*	-	-	-	-	*	-
en_1306.txt	0	26	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	27	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	28	already	RB	(S(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	29	have	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	30	an	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	31	increased	JJ	*	-	-	-	-	*	-
en_1306.txt	0	32	,	,	*	-	-	-	-	*	-
en_1306.txt	0	33	long-term	JJ	*	-	-	-	-	*	-
en_1306.txt	0	34	risk	NN	*)	-	-	-	-	*	-
en_1306.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	36	heart	NN	(NP*	-	-	-	-	*	(1
en_1306.txt	0	37	disease	NN	*))))))))	-	-	-	-	*	1)
en_1306.txt	0	38	,	,	*)	-	-	-	-	*	-
en_1306.txt	0	39	also	RB	(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	40	tend	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	41	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	42	work	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	43	longer	JJR	(NP*	-	-	-	-	*	-
en_1306.txt	0	44	hours	NNS	*)))))))))	-	-	-	-	*	-
en_1306.txt	0	45	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Studies	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	2	show	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	3	an	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	4	association	NN	*)	-	-	-	-	*	-
en_1306.txt	0	5	between	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	6	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	7	factor	NN	*)	-	-	-	-	*	-
en_1306.txt	0	8	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	9	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	10	health	NN	*	-	-	-	-	*	-
en_1306.txt	0	11	effect	NN	*))))))))	-	-	-	-	*	-
en_1306.txt	0	12	should	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	13	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	14	regarded	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	15	as	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	16	no	RB	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	17	more	JJR	*)	-	-	-	-	*	-
en_1306.txt	0	18	than	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	19	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	20	preliminary	JJ	*	-	-	-	-	*	-
en_1306.txt	0	21	result	NN	*)	-	-	-	-	*	-
en_1306.txt	0	22	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	23	points	VBZ	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	24	researchers	NNS	(NP*)	-	-	-	-	*	-
en_1306.txt	0	25	toward	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	26	further	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	27	research	NN	*	-	-	-	-	*	-
en_1306.txt	0	28	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	29	analysis	NN	*))))))))))))	-	-	-	-	*	-
en_1306.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1306.txt	0	1	even	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	2	professional	JJ	*	-	-	-	-	*	-
en_1306.txt	0	3	regulators	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	4	,	,	*	-	-	-	-	*	-
en_1306.txt	0	5	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	6	should	MD	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	7	know	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	8	better	RB	(ADVP*)))))	-	-	-	-	*	-
en_1306.txt	0	9	,	,	*)	-	-	-	-	*	-
en_1306.txt	0	10	sometimes	RB	(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	11	get	VBP	(VP(VP*	-	-	-	-	*	-
en_1306.txt	0	12	sidetracked	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	14	this	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	15	sort	NN	*)	-	-	-	-	*	-
en_1306.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	misapprehension	NN	(NP*))))))	-	-	-	-	*	-
en_1306.txt	0	18	,	,	*	-	-	-	-	*	-
en_1306.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	20	overreact	VB	(VP*))	-	-	-	-	*	-
en_1306.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Last	JJ	(TOP(FRAG(NP*	-	-	-	-	*	-
en_1306.txt	0	1	December	NNP	*)	-	-	-	-	*	-
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	the	DT	(S(NP*	-	-	-	-	*	-
en_1306.txt	0	4	US	NNP	*	-	-	-	-	*	-
en_1306.txt	0	5	Food	NNP	*	-	-	-	-	*	-
en_1306.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	7	Drug	NNP	*	-	-	-	-	*	-
en_1306.txt	0	8	Administration	NNP	*)	-	-	-	-	*	-
en_1306.txt	0	9	issued	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	10	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	11	public	JJ	*	-	-	-	-	*	-
en_1306.txt	0	12	Drug	NNP	*	-	-	-	-	*	-
en_1306.txt	0	13	Safety	NNP	*	-	-	-	-	*	-
en_1306.txt	0	14	Communication	NNP	*)	-	-	-	-	*	-
en_1306.txt	0	15	about	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	16	results	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	17	from	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	18	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	19	large	JJ	*	-	-	-	-	*	-
en_1306.txt	0	20	study	NN	*)	-	-	-	-	*	-
en_1306.txt	0	21	conducted	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	23	France	NNP	(NP*))))))))))	-	-	-	-	*	-
en_1306.txt	0	24	–	SYM	(X*)	-	-	-	-	*	-
en_1306.txt	0	25	the	DT	(NP*	-	-	-	-	*	(2
en_1306.txt	0	26	Santé	NNP	(NAC*	-	-	-	-	*	-
en_1306.txt	0	27	Adulte	NNP	*	-	-	-	-	*	-
en_1306.txt	0	28	GH	NNP	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	29	Enfant	NNP	*)	-	-	-	-	*	-
en_1306.txt	0	30	,	,	*	-	-	-	-	*	-
en_1306.txt	0	31	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	32	SAGhE	NNP	(NP*))	-	-	-	-	*	-
en_1306.txt	0	33	,	,	*)	-	-	-	-	*	-
en_1306.txt	0	34	study	NN	*)	-	-	-	-	*	2)
en_1306.txt	0	35	–	SYM	(X*)	-	-	-	-	*	-
en_1306.txt	0	36	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	37	found	VBD	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	38	an	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	39	increased	JJ	*	-	-	-	-	*	-
en_1306.txt	0	40	risk	NN	*)	-	-	-	-	*	-
en_1306.txt	0	41	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	42	death	NN	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	43	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	44	biosynthetic	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	45	human	JJ	*	-	-	-	-	*	-
en_1306.txt	0	46	growth	NN	*	-	-	-	-	*	-
en_1306.txt	0	47	hormone	NN	*	-	-	-	-	*	-
en_1306.txt	0	48	therapy	NN	*)	-	-	-	-	*	-
en_1306.txt	0	49	relative	JJ	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	50	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	51	the	DT	(NP*	-	-	-	-	*	(3
en_1306.txt	0	52	general	JJ	*	-	-	-	-	*	-
en_1306.txt	0	53	French	JJ	*	-	-	-	-	*	-
en_1306.txt	0	54	population	NN	*))))))))))	-	-	-	-	*	3)
en_1306.txt	0	55	.	.	*	-	-	-	-	*	-
en_1306.txt	0	56	&	CC	*	-	-	-	-	*	-
en_1306.txt	0	57	#	#	(NP*	-	-	-	-	*	-
en_1306.txt	0	58	160	CD	*)	-	-	-	-	*	-
en_1306.txt	0	59	;	:	*))	-	-	-	-	*	-

en_1306.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	were	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	2	93	CD	(NP*	-	-	-	-	*	-
en_1306.txt	0	3	deaths	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	6	treated	VBN	*	-	-	-	-	*	-
en_1306.txt	0	7	group	NN	*))	-	-	-	-	*	-
en_1306.txt	0	8	,	,	*	-	-	-	-	*	-
en_1306.txt	0	9	compared	VBN	(PP*	-	-	-	-	*	-
en_1306.txt	0	10	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	12	70	CD	*)	-	-	-	-	*	-
en_1306.txt	0	13	expected	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	14	from	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	15	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	16	statistical	JJ	*	-	-	-	-	*	-
en_1306.txt	0	17	calculation	NN	*)))))))	-	-	-	-	*	-
en_1306.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	One	CD	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	news	NN	*	-	-	-	-	*	-
en_1306.txt	0	2	article	NN	*)	-	-	-	-	*	-
en_1306.txt	0	3	reported	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	5	study	NN	*	-	-	-	-	*	-
en_1306.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	7	FDA	NNP	*	-	-	-	-	*	-
en_1306.txt	0	8	alert	NN	*)	-	-	-	-	*	-
en_1306.txt	0	9	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	10	this	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	11	headline	NN	*)))	-	-	-	-	*	-
en_1306.txt	0	12	,	,	*	-	-	-	-	*	-
en_1306.txt	0	13	``	``	*	-	-	-	-	*	-
en_1306.txt	0	14	Are	VBP	(SQ*	-	-	-	-	*	-
en_1306.txt	0	15	children	NNS	(NP*)	-	-	-	-	*	-
en_1306.txt	0	16	dying	VBG	(VP*	-	-	-	-	*	-
en_1306.txt	0	17	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	18	an	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	19	inch	NN	*	-	-	-	-	*	-
en_1306.txt	0	20	or	CC	(QP*	-	-	-	-	*	-
en_1306.txt	0	21	two	CD	*))))	-	-	-	-	*	-
en_1306.txt	0	22	?	.	*)	-	-	-	-	*	-
en_1306.txt	0	23	''	''	*	-	-	-	-	*	-
en_1306.txt	0	24	–	SYM	(SBAR(X*)	-	-	-	-	*	-
en_1306.txt	0	25	language	NN	(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	26	guaranteed	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	27	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	28	terrify	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	29	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	30	tens	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	32	thousands	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	33	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	34	patients	NNS	(NP*))	-	-	-	-	*	-
en_1306.txt	0	35	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1306.txt	0	36	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	37	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	38	innumerable	JJ	*	-	-	-	-	*	-
en_1306.txt	0	39	body-builders	NNS	*	-	-	-	-	*	-
en_1306.txt	0	40	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	41	athletes	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	42	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	43	use	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	44	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	45	drug	NN	*	-	-	-	-	*	-
en_1306.txt	0	46	off-label	NN	*)))))	-	-	-	-	*	-
en_1306.txt	0	47	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1306.txt	0	48	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	49	have	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	50	taken	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	51	the	DT	(NP*	-	-	-	-	*	(4
en_1306.txt	0	52	hormone	NN	*)	-	-	-	-	*	4)
en_1306.txt	0	53	over	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	54	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	55	past	JJ	*	-	-	-	-	*	-
en_1306.txt	0	56	26	CD	*	-	-	-	-	*	-
en_1306.txt	0	57	years	NNS	*))))))))))))))))	-	-	-	-	*	-
en_1306.txt	0	58	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	brings	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	2	us	PRP	(NP*)	-	-	-	-	*	(0)
en_1306.txt	0	3	back	RP	(PRT*)	-	-	-	-	*	-
en_1306.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	6	conundrum	NN	*)	-	-	-	-	*	-
en_1306.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	8	correlation	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	9	versus	CC	*	-	-	-	-	*	-
en_1306.txt	0	10	causation	NN	*)))))	-	-	-	-	*	-
en_1306.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(2
en_1306.txt	0	1	French	JJ	*	-	-	-	-	*	-
en_1306.txt	0	2	study	NN	*)	-	-	-	-	*	2)
en_1306.txt	0	3	compared	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	all	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	5	patients	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	6	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	7	took	VBD	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	8	growth	NN	(NP*	-	-	-	-	*	(5
en_1306.txt	0	9	hormone	NN	*)	-	-	-	-	*	5)
en_1306.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	11	the	DT	(NP*	-	-	-	-	*	(3
en_1306.txt	0	12	general	JJ	*	-	-	-	-	*	-
en_1306.txt	0	13	population	NN	*)))))))	-	-	-	-	*	3)
en_1306.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	But	CC	(TOP(S(S*	-	-	-	-	*	-
en_1306.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	2	two	CD	*	-	-	-	-	*	-
en_1306.txt	0	3	groups	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	4	are	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	not	RB	*	-	-	-	-	*	-
en_1306.txt	0	6	at	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	7	all	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	8	comparable	JJ	*))))	-	-	-	-	*	-
en_1306.txt	0	9	:	:	*	-	-	-	-	*	-
en_1306.txt	0	10	kids	NNS	(S(NP(NP*)	-	-	-	-	*	(6
en_1306.txt	0	11	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	12	receive	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	13	the	DT	(NP*	-	-	-	-	*	(7
en_1306.txt	0	14	drug	NN	*)))))	-	-	-	-	*	6)|7)
en_1306.txt	0	15	are	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	16	far	RB	(ADVP*	-	-	-	-	*	-
en_1306.txt	0	17	from	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	18	normal	JJ	(ADJP*)))))	-	-	-	-	*	-
en_1306.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Growth	NN	(TOP(S(NP*	-	-	-	-	*	(5
en_1306.txt	0	1	hormone	NN	*)	-	-	-	-	*	5)
en_1306.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	3	given	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	children	NNS	(NP(NP*)	-	-	-	-	*	(8
en_1306.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	7	various	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	8	kinds	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	10	short	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	11	stature	NN	*))))))))	-	-	-	-	*	8)
en_1306.txt	0	12	.	.	*	-	-	-	-	*	-
en_1306.txt	0	13	These	DT	(S(NP*)	-	-	-	-	*	(8)
en_1306.txt	0	14	include	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	15	growth-hormone	JJ	(SBAR(S(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	16	deficiency	NN	*)	-	-	-	-	*	-
en_1306.txt	0	17	of	IN	(PP(PP*	-	-	-	-	*	-
en_1306.txt	0	18	unknown	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	19	cause	NN	*))	-	-	-	-	*	-
en_1306.txt	0	20	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	21	as	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	22	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	23	result	NN	*)	-	-	-	-	*	-
en_1306.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	25	impairment	NN	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	26	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	27	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	28	pituitary	JJ	*	-	-	-	-	*	-
en_1306.txt	0	29	gland	NN	*))))))	-	-	-	-	*	-
en_1306.txt	0	30	'	''	*))	-	-	-	-	*	-
en_1306.txt	0	31	s	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	32	ability	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	33	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	34	produce	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	35	the	DT	(NP*	-	-	-	-	*	(4
en_1306.txt	0	36	hormone	NN	*)))))	-	-	-	-	*	4)
en_1306.txt	0	37	,	,	*	-	-	-	-	*	-
en_1306.txt	0	38	owing	VBG	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	39	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	40	traumatic	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	41	injury	NN	*	-	-	-	-	*	-
en_1306.txt	0	42	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	43	irradiation	NN	*))	-	-	-	-	*	-
en_1306.txt	0	44	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	45	treat	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	46	cancer	NN	(NP*)))))))))))	-	-	-	-	*	-
en_1306.txt	0	47	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	2	also	RB	(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	3	administered	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	children	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	6	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	7	fail	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	8	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	9	grow	VB	(VP*))))))))	-	-	-	-	*	-
en_1306.txt	0	10	because	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	11	of	IN	*	-	-	-	-	*	-
en_1306.txt	0	12	chronic	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	13	renal	JJ	*	-	-	-	-	*	-
en_1306.txt	0	14	insufficiency	NN	*)	-	-	-	-	*	-
en_1306.txt	0	15	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	16	significant	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	17	genetic	JJ	*	-	-	-	-	*	-
en_1306.txt	0	18	abnormalities	NNS	*))	-	-	-	-	*	-
en_1306.txt	0	19	,	,	*	-	-	-	-	*	-
en_1306.txt	0	20	including	VBG	(PP*	-	-	-	-	*	-
en_1306.txt	0	21	Turner	NNP	(NP(NP*	-	-	-	-	*	(9
en_1306.txt	0	22	syndrome	NN	*)	-	-	-	-	*	9)
en_1306.txt	0	23	,	,	*	-	-	-	-	*	-
en_1306.txt	0	24	Noonan	NNP	(NP*	-	-	-	-	*	-
en_1306.txt	0	25	syndrome	NN	*)	-	-	-	-	*	-
en_1306.txt	0	26	,	,	*	-	-	-	-	*	-
en_1306.txt	0	27	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	28	Prader-Willi	JJ	(NP*	-	-	-	-	*	(10
en_1306.txt	0	29	syndrome	NN	*)))))))	-	-	-	-	*	10)
en_1306.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	These	DT	(TOP(S(NP*	-	-	-	-	*	(6
en_1306.txt	0	1	kids	NNS	*)	-	-	-	-	*	6)
en_1306.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	3	severely	RB	(VP(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	4	impaired	VBN	*))	-	-	-	-	*	-
en_1306.txt	0	5	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Turner	NNP	(TOP(S(NP(NP*	-	-	-	-	*	(9|(10
en_1306.txt	0	1	syndrome	NNP	*)	-	-	-	-	*	9)
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	4	chromosomal	JJ	*	-	-	-	-	*	-
en_1306.txt	0	5	abnormality	NN	*)	-	-	-	-	*	-
en_1306.txt	0	6	in	IN	(SBAR(WHPP*	-	-	-	-	*	-
en_1306.txt	0	7	which	WDT	(WHNP*))	-	-	-	-	*	-
en_1306.txt	0	8	all	DT	(S(NP(NP*	-	-	-	-	*	(11
en_1306.txt	0	9	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	10	part	NN	*)	-	-	-	-	*	-
en_1306.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	12	one	CD	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	14	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	15	sex	NN	*	-	-	-	-	*	-
en_1306.txt	0	16	chromosomes	NNS	*)))))	-	-	-	-	*	11)
en_1306.txt	0	17	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	18	absent	JJ	(ADJP*)))))	-	-	-	-	*	-
en_1306.txt	0	19	,	,	*)	-	-	-	-	*	10)
en_1306.txt	0	20	manifests	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	21	itself	PRP	(NP*)	-	-	-	-	*	(10)
en_1306.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	23	several	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	24	ways	NNS	*)))	-	-	-	-	*	-
en_1306.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	These	DT	(TOP(S(NP*)	-	-	-	-	*	(11)
en_1306.txt	0	1	include	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	2	characteristic	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	3	physical	JJ	*	-	-	-	-	*	-
en_1306.txt	0	4	abnormalities	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	5	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1306.txt	0	6	most	RBS	(ADVP*	-	-	-	-	*	-
en_1306.txt	0	7	often	RB	*)	-	-	-	-	*	-
en_1306.txt	0	8	non-functioning	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	9	ovaries	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	10	,	,	*	-	-	-	-	*	-
en_1306.txt	0	11	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	12	results	VBZ	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	14	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	15	absence	NN	*)	-	-	-	-	*	-
en_1306.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	menstrual	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	18	cycles	NNS	*	-	-	-	-	*	-
en_1306.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	20	sterility	NN	*))))))))	-	-	-	-	*	-
en_1306.txt	0	21	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1306.txt	0	22	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	23	various	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	24	other	JJ	*	-	-	-	-	*	-
en_1306.txt	0	25	health	NN	*	-	-	-	-	*	-
en_1306.txt	0	26	problems	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	27	,	,	*	-	-	-	-	*	-
en_1306.txt	0	28	such	JJ	(PP*	-	-	-	-	*	-
en_1306.txt	0	29	as	IN	*	-	-	-	-	*	-
en_1306.txt	0	30	congenital	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	31	heart	NN	*	-	-	-	-	*	-
en_1306.txt	0	32	disease	NN	*)	-	-	-	-	*	-
en_1306.txt	0	33	,	,	*	-	-	-	-	*	-
en_1306.txt	0	34	low	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	35	thyroid	NN	*	-	-	-	-	*	-
en_1306.txt	0	36	hormone	NN	*	-	-	-	-	*	-
en_1306.txt	0	37	levels	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	38	,	,	*	-	-	-	-	*	-
en_1306.txt	0	39	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	40	autoimmune	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	41	diseases	NNS	*))))))	-	-	-	-	*	-
en_1306.txt	0	42	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Similarly	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	1	,	,	*	-	-	-	-	*	-
en_1306.txt	0	2	Noonan	NNP	(NP(NP*	-	-	-	-	*	(10
en_1306.txt	0	3	syndrome	NN	*)	-	-	-	-	*	10)
en_1306.txt	0	4	,	,	*	-	-	-	-	*	-
en_1306.txt	0	5	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	6	relatively	RB	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	7	common	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	8	genetic	JJ	*	-	-	-	-	*	-
en_1306.txt	0	9	disorder	NN	*)	-	-	-	-	*	-
en_1306.txt	0	10	,	,	*)	-	-	-	-	*	-
en_1306.txt	0	11	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	12	marked	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	13	by	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	14	abnormal	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	15	development	NN	*)	-	-	-	-	*	-
en_1306.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	various	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	18	systems	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	20	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	21	body	NN	*))	-	-	-	-	*	-
en_1306.txt	0	22	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	23	causes	VBZ	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	24	unusual	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	25	facial	JJ	*	-	-	-	-	*	-
en_1306.txt	0	26	characteristics	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	27	,	,	*	-	-	-	-	*	-
en_1306.txt	0	28	short	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	29	stature	NN	*)	-	-	-	-	*	-
en_1306.txt	0	30	,	,	*	-	-	-	-	*	-
en_1306.txt	0	31	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	32	cardiac	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	33	abnormalities	NNS	*)))))))))))	-	-	-	-	*	-
en_1306.txt	0	34	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Prader-Willi	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	syndrome	NN	*)	-	-	-	-	*	-
en_1306.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	3	characterized	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	by	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	5	poor	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	6	muscle	NN	*	-	-	-	-	*	-
en_1306.txt	0	7	tone	NN	*)	-	-	-	-	*	-
en_1306.txt	0	8	,	,	*	-	-	-	-	*	-
en_1306.txt	0	9	low	JJ	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	10	levels	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	12	sex	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	13	hormones	NNS	*)))	-	-	-	-	*	-
en_1306.txt	0	14	,	,	*	-	-	-	-	*	-
en_1306.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	16	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	17	defect	NN	*)	-	-	-	-	*	-
en_1306.txt	0	18	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	19	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	20	part	NN	*)	-	-	-	-	*	-
en_1306.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	22	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	23	brain	NN	*))))	-	-	-	-	*	-
en_1306.txt	0	24	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	25	controls	VBZ	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	26	feelings	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	27	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	28	satiety	NN	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	29	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	30	hunger	NN	*)	-	-	-	-	*	-
en_1306.txt	0	31	,	,	*	-	-	-	-	*	-
en_1306.txt	0	32	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	33	leads	VBZ	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	34	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	35	overeating	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	36	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	37	obesity	NN	*))))))))))))))))	-	-	-	-	*	-
en_1306.txt	0	38	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Thus	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	1	,	,	*	-	-	-	-	*	-
en_1306.txt	0	2	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	3	expect	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	5	same	JJ	*	-	-	-	-	*	-
en_1306.txt	0	6	death	NN	*	-	-	-	-	*	-
en_1306.txt	0	7	rate	NN	*)	-	-	-	-	*	-
en_1306.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	such	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	10	patients	NNS	*)))	-	-	-	-	*	-
en_1306.txt	0	11	as	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	13	the	DT	(NP*	-	-	-	-	*	(3
en_1306.txt	0	14	general	JJ	*	-	-	-	-	*	-
en_1306.txt	0	15	population	NN	*))))))	-	-	-	-	*	3)
en_1306.txt	0	16	would	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	17	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	18	like	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	19	blaming	VBG	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	20	insulin	NN	(NP*)	-	-	-	-	*	-
en_1306.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	22	decreased	VBN	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	23	longevity	NN	*)	-	-	-	-	*	-
en_1306.txt	0	24	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	25	diabetics	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	26	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1306.txt	0	27	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	28	suffer	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	29	cardiac	JJ	(NP(ADJP*	-	-	-	-	*	-
en_1306.txt	0	30	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	31	renal	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	32	disease	NN	*)	-	-	-	-	*	-
en_1306.txt	0	33	more	RBR	(ADVP(ADVP*	-	-	-	-	*	-
en_1306.txt	0	34	frequently	RB	*)	-	-	-	-	*	-
en_1306.txt	0	35	than	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	36	non-diabetics	NNS	(NP*))))))	-	-	-	-	*	-
en_1306.txt	0	37	-RRB-	-RRB-	*))))))))))	-	-	-	-	*	-
en_1306.txt	0	38	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1306.txt	0	1	fact	NN	(NP*))	-	-	-	-	*	-
en_1306.txt	0	2	,	,	*	-	-	-	-	*	-
en_1306.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	-
en_1306.txt	0	4	would	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	6	big	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	7	medical	JJ	*	-	-	-	-	*	-
en_1306.txt	0	8	news	NN	*)	-	-	-	-	*	-
en_1306.txt	0	9	if	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	10	there	EX	(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	11	were	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	12	no	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	13	increase	NN	*)	-	-	-	-	*	-
en_1306.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	15	deaths	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	patients	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	18	treated	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	19	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	20	growth	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	21	hormone	NN	*)))))))))))	-	-	-	-	*	-
en_1306.txt	0	22	,	,	*	-	-	-	-	*	-
en_1306.txt	0	23	because	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	24	that	DT	(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	25	would	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	26	imply	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	27	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	28	the	DT	(S(NP*	-	-	-	-	*	(7
en_1306.txt	0	29	drug	NN	*)	-	-	-	-	*	7)
en_1306.txt	0	30	actually	RB	(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	31	provides	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	32	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	33	life-prolonging	JJ	*	-	-	-	-	*	-
en_1306.txt	0	34	effect	NN	*)	-	-	-	-	*	-
en_1306.txt	0	35	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	36	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	37	population	NN	*)	-	-	-	-	*	-
en_1306.txt	0	38	expected	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	39	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	40	die	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	41	prematurely	RB	(ADVP*)))))))))))))))))	-	-	-	-	*	-
en_1306.txt	0	42	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	Another	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	1	finding	NN	*)	-	-	-	-	*	-
en_1306.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	3	the	DT	(NP*	-	-	-	-	*	(12
en_1306.txt	0	4	SAGhE	NNP	*	-	-	-	-	*	-
en_1306.txt	0	5	study	NN	*)))	-	-	-	-	*	12)
en_1306.txt	0	6	arouses	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	7	skepticism	NN	(NP*)	-	-	-	-	*	-
en_1306.txt	0	8	about	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	10	cause-and-effect	JJ	*	-	-	-	-	*	-
en_1306.txt	0	11	relationship	NN	*)	-	-	-	-	*	-
en_1306.txt	0	12	between	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	(7
en_1306.txt	0	14	drug	NN	*)	-	-	-	-	*	7)
en_1306.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	16	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	17	increased	JJ	*	-	-	-	-	*	-
en_1306.txt	0	18	death	NN	*	-	-	-	-	*	-
en_1306.txt	0	19	rate	NN	*)))))))	-	-	-	-	*	-
en_1306.txt	0	20	:	:	*	-	-	-	-	*	-
en_1306.txt	0	21	the	DT	(S(NP*	-	-	-	-	*	-
en_1306.txt	0	22	mortality	NN	*)	-	-	-	-	*	-
en_1306.txt	0	23	came	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	24	from	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	25	causes	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	26	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1306.txt	0	27	are	VBP	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	28	mechanistically	RB	(ADVP*	-	-	-	-	*	-
en_1306.txt	0	29	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	30	physiologically	RB	*)	-	-	-	-	*	-
en_1306.txt	0	31	quite	RB	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	32	different	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	33	–	SYM	(X(X*)	-	-	-	-	*	-
en_1306.txt	0	34	mainly	RB	(NP(ADVP*)	-	-	-	-	*	-
en_1306.txt	0	35	bone	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	36	cancers	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	37	,	,	*	-	-	-	-	*	-
en_1306.txt	0	38	cardiovascular	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	39	diseases	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	40	,	,	*	-	-	-	-	*	-
en_1306.txt	0	41	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	42	cerebrovascular	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	43	events	NNS	*))))))))))	-	-	-	-	*	-
en_1306.txt	0	44	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	1	more	RBR	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	2	narrow	JJ	*	-	-	-	-	*	-
en_1306.txt	0	3	,	,	*	-	-	-	-	*	-
en_1306.txt	0	4	unimodal	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	5	manifestation	NN	*)	-	-	-	-	*	-
en_1306.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	7	toxicity	NN	(NP*)))	-	-	-	-	*	-
en_1306.txt	0	8	would	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	9	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	10	more	RBR	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	11	persuasive	JJ	*	-	-	-	-	*	-
en_1306.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	13	establishing	VBG	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	14	causation	NN	(NP*)))))))	-	-	-	-	*	-
en_1306.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	American	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	regulators	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	2	jumped	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	3	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	4	gun	NN	*))	-	-	-	-	*	-
en_1306.txt	0	5	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	European	NNP	*	-	-	-	-	*	-
en_1306.txt	0	2	Medicines	NNP	*	-	-	-	-	*	-
en_1306.txt	0	3	Agency	NNP	*)	-	-	-	-	*	-
en_1306.txt	0	4	was	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	more	RBR	(ADJP*	-	-	-	-	*	-
en_1306.txt	0	6	measured	JJ	*)	-	-	-	-	*	-
en_1306.txt	0	7	,	,	*	-	-	-	-	*	-
en_1306.txt	0	8	saying	VBG	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	10	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	11	statement	NN	*))	-	-	-	-	*	-
en_1306.txt	0	12	,	,	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	13	``	``	*	-	-	-	-	*	-
en_1306.txt	0	14	Based	VBN	(S(PP*	-	-	-	-	*	-
en_1306.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	16	this	DT	(NP(NP*	-	-	-	-	*	(12
en_1306.txt	0	17	observational	JJ	*	-	-	-	-	*	-
en_1306.txt	0	18	study	NN	*)	-	-	-	-	*	-
en_1306.txt	0	19	alone	RB	(ADVP*))))	-	-	-	-	*	12)
en_1306.txt	0	20	,	,	*	-	-	-	-	*	-
en_1306.txt	0	21	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	22	risk	NN	*)	-	-	-	-	*	-
en_1306.txt	0	23	cannot	MD	(VP*	-	-	-	-	*	-
en_1306.txt	0	24	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	25	associated	VBN	(VP*	-	-	-	-	*	-
en_1306.txt	0	26	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	27	certainty	NN	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	28	to	TO	(PP*	-	-	-	-	*	-
en_1306.txt	0	29	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	30	growth	NN	*	-	-	-	-	*	-
en_1306.txt	0	31	hormone	NN	*	-	-	-	-	*	-
en_1306.txt	0	32	treatment	NN	*))))))))))))	-	-	-	-	*	-
en_1306.txt	0	33	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1306.txt	0	1	results	NNS	*)	-	-	-	-	*	-
en_1306.txt	0	2	need	VBP	(VP(VP*	-	-	-	-	*	-
en_1306.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_1306.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	5	confirmed	VBN	(VP*)))))	-	-	-	-	*	-
en_1306.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	7	complemented	VBD	(VP*	-	-	-	-	*	-
en_1306.txt	0	8	with	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	9	further	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	10	analyses	NNS	*))))	-	-	-	-	*	-
en_1306.txt	0	11	.	.	*	-	-	-	-	*	-
en_1306.txt	0	12	''	''	*))	-	-	-	-	*	-

en_1306.txt	0	0	There	EX	(TOP(S(S(NP*)	-	-	-	-	*	-
en_1306.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	2	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	3	reproducible	JJ	*	-	-	-	-	*	-
en_1306.txt	0	4	,	,	*	-	-	-	-	*	-
en_1306.txt	0	5	undeniable	JJ	*	-	-	-	-	*	-
en_1306.txt	0	6	association	NN	*)	-	-	-	-	*	-
en_1306.txt	0	7	between	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	8	fires	NNS	(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1306.txt	0	10	fire	NN	(NP*	-	-	-	-	*	-
en_1306.txt	0	11	engines	NNS	*))))))	-	-	-	-	*	-
en_1306.txt	0	12	,	,	*	-	-	-	-	*	-
en_1306.txt	0	13	but	CC	*	-	-	-	-	*	-
en_1306.txt	0	14	that	DT	(S(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	15	doesn	NNS	*	-	-	-	-	*	-
en_1306.txt	0	16	'	POS	*)	-	-	-	-	*	-
en_1306.txt	0	17	t	NN	*)	-	-	-	-	*	-
en_1306.txt	0	18	mean	VBP	(VP*	-	-	-	-	*	-
en_1306.txt	0	19	that	IN	(SBAR*	-	-	-	-	*	-
en_1306.txt	0	20	the	DT	(S(NP*	-	-	-	-	*	-
en_1306.txt	0	21	latter	NN	*)	-	-	-	-	*	-
en_1306.txt	0	22	cause	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	23	the	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	24	former	JJ	*))))))	-	-	-	-	*	-
en_1306.txt	0	25	.	.	*))	-	-	-	-	*	-

en_1306.txt	0	0	If	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1306.txt	0	1	you	PRP	(S(NP(NP*)	-	-	-	-	*	-
en_1306.txt	0	2	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	3	a	DT	(NP*	-	-	-	-	*	-
en_1306.txt	0	4	loved	VBN	*	-	-	-	-	*	-
en_1306.txt	0	5	one	CD	*))	-	-	-	-	*	-
en_1306.txt	0	6	has	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	7	taken	VBN	(VP(VP*)	-	-	-	-	*	-
en_1306.txt	0	8	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1306.txt	0	9	or	CC	*	-	-	-	-	*	-
en_1306.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_1306.txt	0	11	taking	VBG	(VP*))	-	-	-	-	*	-
en_1306.txt	0	12	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1306.txt	0	13	human	JJ	(NP*	-	-	-	-	*	-
en_1306.txt	0	14	growth	NN	*	-	-	-	-	*	-
en_1306.txt	0	15	hormone	NN	*)	-	-	-	-	*	-
en_1306.txt	0	16	under	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	17	a	DT	(NP(NP*	-	-	-	-	*	-
en_1306.txt	0	18	physician	NN	*	-	-	-	-	*	-
en_1306.txt	0	19	'	POS	*)	-	-	-	-	*	-
en_1306.txt	0	20	s	JJ	*	-	-	-	-	*	-
en_1306.txt	0	21	supervision	NN	*))))))	-	-	-	-	*	-
en_1306.txt	0	22	,	,	*	-	-	-	-	*	-
en_1306.txt	0	23	you	PRP	(NP*)	-	-	-	-	*	-
en_1306.txt	0	24	shouldn	VB	(VP*	-	-	-	-	*	-
en_1306.txt	0	25	'	''	*	-	-	-	-	*	-
en_1306.txt	0	26	t	NN	(NP*)	-	-	-	-	*	(13)
en_1306.txt	0	27	lose	VBP	*	-	-	-	-	*	-
en_1306.txt	0	28	sleep	VB	(S(ADJP*	-	-	-	-	*	-
en_1306.txt	0	29	over	IN	(PP*	-	-	-	-	*	-
en_1306.txt	0	30	it	PRP	(NP*)))))	-	-	-	-	*	(13)
en_1306.txt	0	31	.	.	*))	-	-	-	-	*	-

#end document
